131 related articles for article (PubMed ID: 9263643)
1. The molecular epidemiology of lung cancer.
Spivack SD; Fasco MJ; Walker VE; Kaminsky LS
Crit Rev Toxicol; 1997 Jul; 27(4):319-65. PubMed ID: 9263643
[TBL] [Abstract][Full Text] [Related]
2. Metabolic polymorphisms as susceptibility markers for lung and oral cavity cancer.
Nair U; Bartsch H
IARC Sci Publ; 2001; 154():271-90. PubMed ID: 11220667
[TBL] [Abstract][Full Text] [Related]
3. [Individual predisposition to lung neoplasm--the role of genes involved in metabolism of carcinogens].
Butkiewicz D; Chorazy M
Postepy Hig Med Dosw; 1999; 53(5):655-73. PubMed ID: 10645142
[TBL] [Abstract][Full Text] [Related]
4. [Biology of bronchial cancer. Molecular epidemiology].
Urban T
Rev Mal Respir; 1999 Jan; 16 Suppl 3():S13-4. PubMed ID: 10088222
[No Abstract] [Full Text] [Related]
5. The molecular epidemiology of lung cancer.
Schwartz AG; Prysak GM; Bock CH; Cote ML
Carcinogenesis; 2007 Mar; 28(3):507-18. PubMed ID: 17183062
[TBL] [Abstract][Full Text] [Related]
6. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
Pavanello S; Clonfero E
G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
[TBL] [Abstract][Full Text] [Related]
7. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide.
Pastorelli R; Guanci M; Cerri A; Negri E; La Vecchia C; Fumagalli F; Mezzetti M; Cappelli R; Panigalli T; Fanelli R; Airoldi L
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):703-9. PubMed ID: 9718223
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer in never smokers: a review.
Subramanian J; Govindan R
J Clin Oncol; 2007 Feb; 25(5):561-70. PubMed ID: 17290066
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.
Bartsch H; Nair U; Risch A; Rojas M; Wikman H; Alexandrov K
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):3-28. PubMed ID: 10667460
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of lung cancer in female passive smokers.
Yang M; Pyo MY
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(1):75-97. PubMed ID: 16291523
[TBL] [Abstract][Full Text] [Related]
11. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Schwartz AG
Carcinogenesis; 2005 Feb; 26(2):395-401. PubMed ID: 15528218
[TBL] [Abstract][Full Text] [Related]
12. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M
Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728
[TBL] [Abstract][Full Text] [Related]
13. Can't lung cancer patients detoxify procarcinogens?
Cerrahoglu K; Kunter E; Isitmangil T; Oztosun AI; Isitmangil G; Okutan O; Bozkanat E; Aydilek R; Bener A
Allerg Immunol (Paris); 2002 Feb; 34(2):51-5. PubMed ID: 11939169
[TBL] [Abstract][Full Text] [Related]
14. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population.
Hirvonen A; Husgafvel-Pursiainen K; Karjalainen A; Anttila S; Vainio H
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):485-9. PubMed ID: 1284589
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene.
Lind H; Zienolddiny S; Ryberg D; Skaug V; Phillips DH; Haugen A
Lung Cancer; 2005 Dec; 50(3):285-90. PubMed ID: 16126303
[TBL] [Abstract][Full Text] [Related]
16. DNA adduct burden and tobacco carcinogenesis.
Wiencke JK
Oncogene; 2002 Oct; 21(48):7376-91. PubMed ID: 12379880
[TBL] [Abstract][Full Text] [Related]
17. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
18. Biologic damage resulting from exposure to tobacco smoke and from radon: implication for preventive interventions.
Alavanja MC
Oncogene; 2002 Oct; 21(48):7365-75. PubMed ID: 12379879
[TBL] [Abstract][Full Text] [Related]
19. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
Badawi AF; Stern SJ; Lang NP; Kadlubar FF
Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
